Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer

International Journal of Colorectal Disease

Volumn 24, Issue 2, 2009, Pages 219-224

  Fakih, Marwan G ^a   Trump, Donald L ^a   Johnson, Candace S ^b   Tian, Lili ^c   Muindi, Josephia ^a   Sunga, Annette Y ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

25 hydroxy vitamin D; Chemotherapy; Colorectal cancer; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ANTINEOPLASTIC AGENT; BEVACIZUMAB; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN;

ADULT; AGE; ARTICLE; BODY MASS; CANCER STAGING; CHEMOLUMINESCENCE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; TUMOR LOCALIZATION; VITAMIN D DEFICIENCY;

EID: 58549094271     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-008-0593-y     Document Type: Article

References (32)

1. Garland CF, Garland FC (1980) Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 9(3):227-231
2. Holick M (2007) Vitamin D Deficiency. NEJM 357:266-281
3. Garland CF et al (1989) Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2(8673):1176-1178
4. Tangrea J et al (1997) Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 8(4):615-625
5. Feskanich D et al (2004) Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 13(9):1502-1508
6. Wactawski-Wende J et al (2006) Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 354(7):684-696
7. Wu K et al (2007) A nested case-control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst 99(14):1120-1129
8. Niv Y et al (1999) In colorectal carcinoma patients, serum vitamin D levels vary according to stage of the carcinoma. Cancer 86(3):391-397
9. Levine AJ et al (2001) Serum 25-hydroxyvitamin D, dietary calcium intake, and distal colorectal adenoma risk. Nutr Cancer 39(1):35-41
10. Grau MV et al (2003) Vitamin D, calcium supplementation, and colorectal adenomas: Results of a randomized trial. J Natl Cancer Inst 95(23):1765-1771
11. Zhou W et al (2007) Circulating 25-hydroxyvitamin d levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol 25(5):479-485
12. Hollis BW (2005) Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: Implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 135(2):317-322
13. Thomas MG et al (1999) Vitamin D receptor expression in colorectal cancer. J Clin Pathol 52(3):181-183
14. Meggouh F et al (1990) Evidence of 1,25-dihydroxyvitamin D3-receptors in human digestive mucosa and carcinoma tissue biopsies taken at different levels of the digestive tract, in 152 patients. J Steroid Biochem 36(1-2):143-147
15. Cross HS et al (1996) Vitamin D receptor and cytokeratin expression may be progression indicators in human colon cancer. Anticancer Res 16(4B):2333-2337
16. Evans SR et al (1998) Vitamin D receptor expression as a predictive marker of biological behavior in human colorectal cancer. Clin Cancer Res 4(7):1591-1595
17. Matusiak D et al (2005) Expression of vitamin D receptor and 25-hydroxyvitamin D3-1{alpha}-hydroxylase in normal and malignant human colon. Cancer Epidemiol Biomarkers Prev 14(10):2370-2376
18. Kallay E et al (2001) Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage. Carcinogenesis 22(9):1429-1435
19. Kallay E et al (2002) Vitamin D receptor activity and prevention of colonic hyperproliferation and oxidative stress. Food Chem Toxicol 40(8):1191-1196
20. Holt PR et al (2006) Calcium plus vitamin D alters preneoplastic features of colorectal adenomas and rectal mucosa. Cancer 106(2):287-296
21. Holt PR et al (2002) Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D. Cancer Epidemiol Biomarkers Prev 11(1):113-119
22. Miller EA et al (2007) Calcium, dietary, and lifestyle factors in the prevention of colorectal adenomas. Cancer 109(3):510-517
23. Peters U et al (2001) Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. Cancer Epidemiol Biomarkers Prev 10(12):1267-1274
24. Gorham ED et al (2007) Optimal vitamin D status for colorectal cancer prevention: A quantitative meta analysis. Am J Prev Med 32(3):210-216
25. Braun MM et al (1995) Colon cancer and serum vitamin D metabolite levels 10-17 years prior to diagnosis. Am J Epidemiol 142(6):608-611
26. Ng K et al (2008) Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol 26(18):2984-2991
27. Boscoe FP, Schymura MJ (2006) Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2002. BMC Cancer 6:264
28. Otani T et al (2007) Plasma vitamin D and risk of colorectal cancer: The Japan Public Health Center-Based Prospective Study. Br J Cancer 97(3):446-451
29. Sinicrope FA et al (2006) Microsatellite instability accounts for tumor site-related differences in clinicopathologic variables and prognosis in human colon cancers. Am J Gastroenterol 101(12):2818-2825
30. Camps J et al (2006) Genome-wide differences between microsatellite stable and unstable colorectal tumors. Carcinogenesis 27(3):419-428
31. Edmonston TB et al (2000) Colorectal carcinomas with high microsatellite instability: Defining a distinct immunologic and molecular entity with respect to prognostic markers. Hum Pathol 31(12):1506-1514
32. Adams JS et al (2007) Vitamin D in defense of the human immune response. Ann N Y Acad Sci 1117:94-105